Equillium Inc (EQ) support and resistance · rev $41.1M
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
This page maps Equillium Inc (EQ) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
EQ currently screens at market cap $189.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new EQ 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the EQ quote page for the session range and the stock page for the full model.
Not investment advice.